This is a very broad question intended to initiate an exchange of ideas or current best practices from which we can all benefit and promote the the practice of continuous manufacturing: In transitioning from discrete batch manufacturing - be it API or pharmaceutical processing - how have you or how would you modify your current quality control methodologies to ensure product quality while simultaneously mitigating financial risks? Please share your experiences, your successes and challenges.
STEPHEN LERMER @ on
This is a very broad question intended to initiate an exchange of ideas or current best practices from which we can all benefit and promote the the practice of continuous manufacturing: In transitioning from discrete batch manufacturing - be it API or pharmaceutical processing - how have you or how would you modify your current quality control methodologies to ensure product quality while simultaneously mitigating financial risks? Please share your experiences, your successes and challenges.